Particle.news

Measles Resurgence Pushes Mexico Toward Outbreak Control and Ends U.S. Elimination Status

PAHO's ruling shows drops in two‑dose vaccine coverage have allowed prolonged measles circulation across the Americas.

Overview

  • PAHO concluded in mid‑November that the United States no longer meets measles‑elimination criteria after sustained local transmission during 2025–2026.
  • Mexico reported 20,701 confirmed measles cases and 50 deaths through November 12, 2026, has administered 40.9 million vaccine doses, and currently shows about 90% reported coverage with six active cases.
  • Mexican health authorities have launched a 90‑day outbreak response that includes intensified surveillance, local vaccination 'blocking' and mass campaigns with the goal of reaching 95% coverage to interrupt remaining transmission and aim to close the outbreak by the second half of 2027.
  • U.S. public‑health reports show more than 5,400 cases in 2026 with multiple deaths and clinicians and CDC‑linked data documenting 13 cases of congenital measles plus 112 confirmed infections during pregnancy.
  • Experts trace the regional rebound to falling two‑dose measles vaccination and uneven access to services, especially in rural and marginalized communities, and warn that restoring homogeneous ≥95% coverage, lab and surveillance capacity, and rapid local responses are needed to prevent further spread and other vaccine‑preventable harms.